Insider buying last 90 days
No open-market insider purchases were filed for CBT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Cabot's Q3 2026 results, reported this week, showed adjusted EPS rising 4% sequentially to $1.67, with strength in the Performance Chemicals segment offsetting other pressures. The company also announced a leadership transition, with Erica McLaughlin set to succeed Sean Keohane as CEO. Separately, shares were noted trading at $79.47 with a GF Score of 82/100, and a filing showed State Street Corp raising its stake in Cabot, alongside disclosed insider sales including from Keohane.
Cabot closed at $78.45, down 0.4%, with the stock sitting between its 50-day average of $83.95 and 200-day average of $78.76, reflecting a mixed trend. Shorter-term returns show a 1-month decline of 7.2% and a 3-month decline of 13.2%, while the 6-month return stands at 5.9% and the 1-year return at 3.9%. The GekkoIndex reads 63.7, placing Cabot in the Accumulation zone, down 6.1 over five sessions. The gap to Gekko Fair Value of $102.11 stands at 23.2% below current price.
Cabot's next earnings date falls on 2 November 2026, 34 days away, outside a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the current windows. Seasonally, the next 20 trading days have averaged a 1.1% gain over 5 years, rising in 3 of them. Analyst consensus among 3 firms includes 2 buy ratings and 1 hold, with a consensus target of $91.33, implying 16.4% upside from current levels.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Cabot scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
Averages disagree
Close $78.45 sits between the 50-day ($83.95) and 200-day ($78.76) averages, or the averages disagree.
See the chart63.7, Accumulation
Reading 63.7 is in the Accumulation zone.
See the GekkoIndex23.2% below
Price is 23.2% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 34 days
Next report Nov 2, 2026, 34 days away — outside a typical 20-trading-day hold.
See earnings+1.1% on average
From this point in the calendar, the next 20 trading days averaged +1.1% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Cabot closed at $78.45 on Sep 28, 2026, +3.9% over the past year, inside a 52-week range of $58.33 to $94.53.
Use the left and right arrow keys to read daily values.
Put CBT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Cabot makes specialty chemicals and performance materials, with a strong focus on carbon-based products. It is best known for reinforcing carbons that strengthen rubber in tires and in industrial goods like hoses, belts, and molded parts, alongside engineered elastomer composites. Its broader catalog includes specialty carbons for inks, coatings, plastics, and batteries, plus fumed silica and fumed alumina used in adhesives, cosmetics, coatings, and battery components for electric vehicles.
The company is structured around two segments, Reinforcement Materials and Performance Chemicals, which together cover its carbon and specialty additive lines. Additional offerings include aerogel insulation particles, masterbatch and conductive compounds for automotive, packaging, and electronics uses, inkjet colorants, carbon nanotubes, and fumed metal oxides. Cabot reaches customers through distributors and sales representatives across the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Cabot traces its founding to 1882 and is headquartered in Boston, Massachusetts. Its shares are listed on the NYSE under the ticker CBT.
Cabot’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 63.7, in the Accumulation zone, down 6.1 points over five sessions.
Down 6.1 points over five sessions.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 51 | +0.7% | −0.7% | ||
| Accumulation (current zone) | 220 | −0.2% | −1.2% | ||
| Neutral | 375 | +0.3% | +1.5% | ||
| Distribution | 25 | −0.7% | +1.7% | ||
| Selling | 1 | Too few readings yet | |||
Average CBT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Cabot trades 23.2% below Gekko Fair Value of $102.11, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Cabot shares are worth, recalculated every trading day.
$102.11
Gekko Fair Value, Sep 29, 2026
23.2% Undervalued
No open-market insider purchases were filed for Cabot, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for CBT in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in CBT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Cabot has been buying back its own shares.
From company filings.
Cabot reports on Nov 2, 2026, before the open (34 days away), and beat the EPS estimate in 7 of its last 8 reports.
Nov 2, 2026
Expected before the open, 34 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Feb 3, 2026 | $1.53 est $1.40 | $849.0M est $887.0M | +8.1% |
| Nov 3, 2025 | $1.70 est $1.68 | $899.0M est $930.0M | −9.2% |
| Aug 4, 2025 | $1.90 est $1.82 | $923.0M est $977.6M | +11.2% |
| May 5, 2025 | $1.90 est $1.85 | $936.0M est $955.0M | −7.1% |
| Feb 3, 2025 | $1.76 est $1.77 | $955.0M est $1.03B | +2.0% |
| Nov 4, 2024 | $1.80 est $1.79 | $1.00B est $1.01B | −0.1% |
| Aug 5, 2024 | $1.92 est $1.72 | $1.02B est $1.00B | +12.6% |
| May 6, 2024 | $1.78 est $1.66 | $1.02B est $1.04B | +7.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Cabot is $91.33, +16.4% from the last close, from 3 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 3 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 22 | Jefferies | $98 | +24.9% |
| Aug 10 | Truist Financial | — | — |
| Aug 5 | Truist Financial | $100 | +27.5% |
| Aug 5 | UBS | $92 | +17.3% |
| Jul 6 | UBS | $97 | +23.6% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 26, Cabot averaged +1.1% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.1% | 3 of 5 |
| Next 10 trading days | −1.1% | 3 of 5 |
| Next 15 trading days | +1.8% | 4 of 5 |
| Next 20 trading days | +1.1% | 3 of 5 |
| Next 30 trading days | +5.4% | 4 of 5 |
For scale, CBT’s typical 20-trading-day move in either direction is about 5.9%.
Cabot’s market cap is $4.05B, with a P/E ratio of 22.1 and revenue of $3.63B over the last twelve months.
3 headlines about Cabot from the past week, newest first, each linking to the publisher.
Cabot’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LINLinde | Accumulation | 2.8% below |
| ECLEcolab | Neutral | 8.2% above |
| APDAir Products and Chemicals | Accumulation | 11.9% below |
| DOWDow | Accumulation | 34.3% below |
| LYBLyondellBasell Industries | Accumulation | 12.3% below |
| ALBAlbemarle | Accumulation | 24.7% below |
A peer links to its own page where one exists.
Cabot’s market cap is $4.05B at the Sep 28, 2026 close of $78.45, with 51.63M shares outstanding. The shares trade on a P/E ratio of 22.1.
The consensus analyst 12-month price target for Cabot is $91.33, +16.4% from the last close. Of the 3 firms that rated the stock in the last 90 days, 2 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Cabot is undervalued: the Sep 28, 2026 close of $78.45 is 23.2% below Gekko Fair Value of $102.11. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Cabot is expected to report on Nov 2, 2026, before the market opens (34 days away). Analysts expect earnings of $1.55 per share on revenue of $924.1M. Cabot beat the earnings estimate in 7 of its last 8 reports, moving 7.2% on average across the report.
Cabot’s 52-week high is $94.53 and its 52-week low is $58.33; it closed at $78.45 on Sep 28, 2026, +3.9% over the past year. Over the last five years the shares peaked at $117.46 on Nov 7, 2024.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.